Abstract:Cardiovascular diseases are caused by hypercholesterolemia. Astaxanthin (AST) has been reported to exhibit antioxidant and anti-inflammatory properties. However, its bioavailability is poor because of low solubility and instability. In order to improve the bioavailability of AST, we developed an intestinal-responsive composite carrier termed as "liposomes in micropheres" incorporating N-succinyl-chitosan (NSC)-poly(ethylene glycol) (PEG) liposomes that functionalized by neonatal Fc receptors (FcRn) into hydrogels of sodium alginate (SA) and carboxymethyl chitosan (CMCS). In the AST NSC/HSA-PEG liposomes@SA/CMCS microspheres, the AST's encapsulation efficiency (EE) was 96.26% (w/w) and its loading capacity (LC) was 6.47% (w/w). AST NSC/HSA-PEG liposomes had stability in the gastric conditions and achieved long-term release of AST in intestinal conditions. Then, AST NSC/HSA-PEG liposomes@SA/CMCS bind to intestinal epithelial cell targets by the neonatal Fc receptor. In vitro permeation studies show that there was a 4-fold increase of AST NSC/HSA-PEG liposomes@SA/CMCS in AST permeation across the intestinal epithelium. Subsequent in vivo experiments demonstrated that the composite carrier exhibited a remarkable mucoadhesive capacity, allowing for extended intestinal retention of up to 12 h, and it displayed deep penetration through the mucus layer, efficiently entering the intestinal villi epithelial cells, and enhancing the absorption of AST and its bioavailability in vivo. And oral administration of AST NSC/HSA-PEG liposomes@SA/CMCS could effectively prevent hypercholesterolemia caused by a high-fat, high-cholesterol diet (HFHCD). These advancements highlight the potential of NSC/HSA-PEG liposomes@SA/CMCS composite carriers for targeted and oral uptake of hydrophobic bioactives.

Preparation and Characterization of Phosphatidyl-Agar Oligosaccharide Liposomes for Astaxanthin Encapsulation

Preparation and characterization of astaxanthin-loaded liposomes by phytosterol oleate instead of cholesterol

Preparation of Astaxanthin-Loaded Liposomes: Characterization, Storage Stability and Antioxidant Activity

Enhancement of Astaxanthin Bioaccessibility by Encapsulation in Liposomes: An In Vitro Study

Preparation and Characterization of Astaxanthin-loaded Liposomes Stabilized by Sea Cucumber Sulfated Sterols Instead of Cholesterol

Effect of Membrane Surface Modification Using Chitosan Hydrochloride and Lactoferrin on the Properties of Astaxanthin-Loaded Liposomes

Surface modification by chitosan for improving stability and antioxidative activity of astaxanthin-loaded liposomes

Preparation, characterization, and stability of chitosan-tremella polysaccharide layer-by-layer encapsulated astaxanthin nanoemulsion delivery system

Preparation of astaxanthin-loaded composite micelles with coaxial electrospray technology for enhanced oral bioavailability and improved antioxidation capability

Preparation of Astaxanthin-loaded Composite Micelles via Coaxial Electrospray Technology for Enhanced Oral Bioavailability and Improved Antioxidation Capability.

Zein/hyaluronic acid nanoparticle stabilized Pickering emulsion for astaxanthin encapsulation

Design of Astaxanthin-Loaded Core-Shell Nanoparticles Consisting of Chitosan Oligosaccharides and Poly(lactic- co-glycolic acid): Enhancement of Water Solubility, Stability, and Bioavailability.

Formation, Characterization, and Application of Chitosan/pectin-Stabilized Multilayer Emulsions As Astaxanthin Delivery Systems

Preparation and Stability of Nanoparticles Containing Astaxanthin from Haematococcus pluvialis

Influence of gelatinized octenyl succinic anhydride-modified waxy adlay seed starch on the properties of astaxanthin-loaded emulsions: Emulsion properties, stability and in vitro digestion properties

Preparation and in vitro characterization studies of astaxanthin-loaded nanostructured lipid carriers with antioxidant properties

Extraction of Astaxanthin from Haematococcus pluvialis and Preparation of Astaxanthin Liposomes

Enhancing the Stability of Astaxanthin by Encapsulation in Poly (L-Lactic Acid) Microspheres Using a Supercritical Anti-Solvent Process

Microencapsulation of Astaxanthin Based on Emulsion Solvent Evaporation and Subsequent Spray Drying.

Prevention of Hypercholesterolemia with "Liposomes in Microspheres" Composite Carriers: A Promising Approach for Intestinal-Targeted Oral Delivery of Astaxanthin

Optimization and characterization of poly(lactic-co-glycolic acid) nanoparticles loaded with astaxanthin and evaluation of anti-photodamage effect in vitro